historical are restated accordingly Strategic fit 10 EMEA contributed 36% of the Company’s core EBITDA. On a LTM basis, produc- tion in EMEA has increased as a result of the full year benefit of PTA, IPA
improvements seen in the 2H17 performance vis-à-vis what we saw during the first half of the year 2017. While production was higher by 6%, EBITDA increased by 20%, highlighting the improve- ment seen on the
benefit expenses (4.72) (4.17) (0.55) (113.19) Financial cost (0.32) (0.04) (0.28) (800.00) Share of loss in associates - (12.84) (12.84) - Total expenses (19.16) (91.05) (71.89) (21.04) Profit (Loss
investors. However, the underwriter is required to purchase those shares at a later date, resulting in higher demand when share price is below initial public offering price. In contrary, higher number of
addition, the valuation of each business may be increased or decreased according to the change of business circumstance and relevant factors in the near future while the fixing of the base price with certain
$250,000 General Information Class E (Institutional Accumulation) USD Inception Date August 19, 2020 ISIN Code IE00BKVDGT87 Bloomberg BRRUUEA Net Asset Value Per Share $23.23 Assets by Sector2 Assets by
trust does not have any remaining accumulated profit; (c) the trust increased the capital to acquire an infrastructure asset but was failed to do so; (d) the trust has non-cash expenses that are not